跳至主要内容
临床试验/JPRN-UMIN000049833
JPRN-UMIN000049833招募中Unknown

Effect of Neoadjuvant Chemotherapy on Homologous Recombination Repair Ability in Epithelial Ovarian Cancer - JIKEI P-HDR Study

The Jikei University0 个研究点目标入组 35 人开始时间: 2023年4月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 80years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • (1) Patients with contraindications to either paclitaxel or carboplatin. (2) Patients with poorly controlled cardiac disease, renal disease, or diabetes mellitus. (3) Patients with interstitial pneumonia or pulmonary fibrosis (to be confirmed by CT scan). (4) Patients with intestinal paralysis or intestinal obstruction that is poorly controlled. (5) Patients with infectious diseases requiring treatment. (6) Patients with a history of radiation therapy to the chest or abdomen. (7) Patients with active multiple cancers (not including intraepithelial cancer). (viii) Patients with a history of serious drug hypersensitivity. (9) Patients with symptomatic central nervous system metastasis. (10) Patients who are pregnant or lactating. (11) Patients who are currently receiving or have recently received other investigational drugs (including unapproved drugs). (12) Patients who are judged to be inappropriate to participate in this study by the investigators or co-investigators.

研究者

发起方
The Jikei University

相似试验